Ajanta Pharma gets approvals for three Abbreviated New Drug Applications
Ajanta Pharma has received final approval for its three Abbreviated New Drug Application (ANDAs) by US FDA for Montelukast…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
DRL and Purdue varsity in drug research Memorandum of Understanding
To forge a strategic partnership in a range of research areas and novel technologies in the field of pharma processes and product…
Syngene International Initial Public Offering oversubscribed 31 times
The IPO is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene
PHD chamber conducts national conference on ‘Pharma Exports: API Challenges’ in New Delhi
Policy makers disclosed initiatives, policies and schemes for betterment of the pharma sector
Sun Pharma, HCL and TCS in Forbes list of world’s most innovative companies
Sun Pharma bags 71st position
DRL recalls Rivastigmine Tartrate capsules from US
A total of 60 bottles of 2952 units are recalled on the direction of US FDA
US FDA warning letter to have no material impact on Mylan biz: CEO
Company claims to make important progress on FDA's observations
US FDA approves first treatment for sexual desire disorder
Addyi approved to treat premenopausal women
Aurobindo Pharma receives US FDA approval for Omeprazole delayed-release capsules
Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults
New strategies for growth
After a decade of pain, there are some reassuring signs that the pharmaceutical industry may just be seeing the faint glimmers of…